Prostate specific antigen screening for prostate cancer: Knowledge of, attitudes towards, and utilization among primary care physicians
Authors:
- Gregory E. TasianGTGregory E. Tasian
- Matthew R. CooperbergMCMatthew R. Cooperberg
- Kian KeyashianKKKian Keyashian
- June M. ChanJCJune M. Chan
- 1 March 2012
- journal article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 30 (2) , 155-160
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Prostate Cancer Screening DecisionsArchives of internal medicine (1960), 2009
- Active surveillance with selective delayed intervention for favorable risk prostate cancerUrologic Oncology: Seminars and Original Investigations, 2006
- Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per MilliliterNew England Journal of Medicine, 2004
- To screen or not to screen, when clinical guidelines disagree: primary care physicians' use of the PSA testPreventive Medicine, 2004
- Practice trends in the management of prostate disease by family practice physicians and general internists: an internet-based surveyUrology, 2002
- Impact of Screening on Incidence and Mortality of Prostate Cancer in the United StatesEpidemiologic Reviews, 2001
- Immediate Hormonal Therapy Compared with Observation after Radical Prostatectomy and Pelvic Lymphadenectomy in Men with Node-Positive Prostate CancerNew England Journal of Medicine, 1999
- Prostate-specific antigen for prostate cancer screening Do physician characteristics affect its use?American Journal of Preventive Medicine, 1999
- American College of Preventive Medicine practice policyAmerican Journal of Preventive Medicine, 1998
- Determinants of prostate-specific antigen test use in prostate cancer screening by primary care physiciansArchives of Family Medicine, 1997